Product
Sodium-glucose cotransporter 2 inhibitor
3 clinical trials
5 indications
Indication
Type 2 DiabetesIndication
Cardiac DiseaseIndication
SGLT2 Inhibitors Remodeling EffectIndication
Chronic Heart DiseaseIndication
Congestive Heart FailureClinical trial
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease RiskStatus: Active (not recruiting), Estimated PCD: 2025-04-01
Clinical trial
Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart FailureStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
Investigation of Biomarker Response to SGLT2 Inhibition Across Various Phenotypes of Heart FailureStatus: Recruiting, Estimated PCD: 2024-09-01